A difficult transformation is underway at Cipla, one of India’s largest and oldest pharma companies.

Hamied celebrated his 81st birthday last week.

The pharma industry is not like cement or sugar where you go on making it year in year out and there is no change. Here the older drugs die...

Cipla is keeping all avenues open for appropriate licensing agreements with other global companies to make patients better secured for affo...

Vaziralli, daughter of MK Hamied -- the company's non-executive VC - has been a part of the core leadership team since joining the Mumbai-b...

Cipla patriarch YK Hamied plans to increase his holding to over 20 per cent by acquiring over 5 per cent additional stake in the homegrown ...

Cipla has urged the government to focus on supporting capital investment, encouraging research and create a favourable tax regime to help g...

Samina Vaziralli, niece of Cipla Chairman YK Hamied, was appointed to the company's board on Thursday, thus inducting the next generation.

Now if you look at the world’s top 70 drugs, 50% of them or more are made and marketed by companies that did not invent them.

Oberoi in his new role as 'Executive Chairman' will look after the renovations of existing hotels and future projects.

"It is very important for the government to take the indigenous industry seriously. We are not consulted on any issue," says Dr Hameid.

Kidney cancer drug will now be available at Rs 6,840 for a month's supply, down from Rs 28,000. Lung cancer drug will cost Rs 4,250, down f...

In an interview with ET Now, Dr YK Hamied, CMD, Cipla, talks about the pharma sector and company's strategies. Excerpts:

Pharma major Cipla on Thursday said it is expecting to scale up its revenue by over six times to Rs 15,000-20,000 crore.

In an exclusive interview with ET Now, pharmaceutical guru Dr. YK Hamied, CMD, Cipla analyses the broad trends in the Indian pharmaceutical...

Cipla plans to raise Rs 1,500 crore either by issuing foreign currency convertible bonds or through global depository receipts to clear its...

The lack of clarity on the succession issue may have impacted the functioning of many family-owned Indian companies. But the septuagenarian...